UK markets open in 1 hour 45 minutes

Paion AG (0NF3.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.0241-0.1989 (-89.19%)
At close: 05:19PM BST

Paion AG

Heussstrasse 25
Aachen 52078
Germany
49 2414 4530
https://www.paion.com

Sector(s): 
Industry: 
Full-time employees: 64

Key executives

NameTitlePayExercisedYear born
Mr. Sebastian WernerMember of Management Board & CFO218.79kN/AN/A
Mr. Tilmann BurMember of Management Board & CEON/AN/A1965
Ralf PennerVice President of Investor Relations & Public RelationsN/AN/AN/A
Dr. Thomas StoehrSenior Vice President of DevelopmentN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and intensive care medicine services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation. It is also developing Angiotensin II, a vasoconstrictor indicated for the treatment of refractory hypotension in adults with septic or other distributive shock; and Eravacycline, a novel fluorocycline antibiotic indicated for the treatment of complicated intra-abdominal infections in adults. The company has partnerships and license agreements with Cosmo Pharmaceuticals, Hana Pharm, Yichang Humanwell, and Mundipharma. Paion AG was founded in 2000 and is based in Aachen, Germany.

Corporate governance

Paion AG’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.